跳至主要内容
临床试验/EUCTR2018-000889-11-NO
EUCTR2018-000889-11-NO进行中(未招募)1 期

Randomized Evaluation of Beta Blocker and ACE-Inhibitor/Angiotensin Receptor Blocker Treatment in MINOCA patients - MINOCA-BAT - MINOCA-BAT

Department of Medical Sciences, Akademiska sjukhuset0 个研究点目标入组 3,500 人开始时间: 2020年8月25日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
3,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Age >18 years.
  • 2.A clinical diagnosis of MINOCA within the last 30 days.
  • 3.Left ventricular ejection fraction =40% measured with echocardiography, MRI or left ventriculography during hospitalization and prior to randomization.
  • 4.Written informed consent obtained
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • 1.Any condition that may influence the patient's ability to comply with study protocol.
  • 2.Previous revascularization (CABG or PCI)
  • 3.Clinical signs of heart failure
  • 4.MRI-proven myocarditis or a strong clinical suspicion of myocarditis as cause of the index event
  • 5.Contraindications for beta-blockade
  • 6.Contraindications for ACEI and ARB
  • 7.Prior use of ACE-I, ARB, or beta blockers, which must continue according to treating physician.
  • 8.New indication for beta-blockade or ACEI/ARB other than as secondary prevention according the investigator
  • 9.Ongoing pregnancy or woman of childbearing potential not using highly effective contraceptives
  • 9.Participation in a trial evaluating a drug known to interact with beta blockers or ACEI/ARB

研究者

发起方
Department of Medical Sciences, Akademiska sjukhuset

相似试验

进行中(未招募)
1 期
Registry based randomized study of Beta blocker, ACE Inhibitor and Angiotensin Receptor Blocker in patients discharged with myocardial infarction with non-obstructive coronary artery disease (MINOCA-BAT)Myocardial infarction with non-obstructive coronary artery disease (MINOCA).
EUCTR2018-000889-11-SEDepartment of Medical Sciences, Uppsala Universitet3,500
进行中(未招募)
1 期
Registry based randomized study of Beta blocker, ACE Inhibitor and Angiotensin Receptor Blocker in patients discharged with myocardial infarction with non-obstructive coronary artery disease (MINOCA-BAT)Myocardial infarction with non-obstructive coronary artery disease (MINOCA).
EUCTR2018-000889-11-ESDepartment of Medical Sciences, Uppsala Universitet3,500
终止
4 期
Can Heart attack patients without coronary artery blockages benefit from standard heart attack medical treatment strategies?Myocardial Infarction With Non-obstructive Coronary ArteriesCardiovascular - Coronary heart disease
ACTRN12618001858280The University of Adelaide71
进行中(未招募)
不适用
A prospective study with beta-blockers and ACE-inhibitors in patients operable breast cancer experiencing mild cardiac toxicity during treatment with anthracycline and/or trastuzumabpatients experiencing mild cardiotoxicity during treatment with anthracycline and/or trastuzumab for operable breast cancer
EUCTR2011-002207-15-ITFONDAZIONE DEL PIEMONTE PER L'ONCOLOGIA IRCC DI CANDIOLO
招募中
3 期
Investigating the effectiveness of beta-blocker on hypermetabolic response in adult patients due to acute burns
IRCT20230301057584N1Bandare-abbas University of Medical Sciences90